DUBLIN--(BUSINESS WIRE)--The "Zelboraf- Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
Zelboraf Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.
Scope
- A review of the Zelboraf, based on information derived from company and industry-specific sources
- Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the Drug Master Files and API Manufacturers by country
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Forecasted Sales Figure from 2019-2021
- Market competition and emerging therapies
- SWOT Analysis
Topics Covered
1. Report Introduction
2. Zelboraf - Overview
- Product Description
- Route of Synthesis
- Mechanism of Action
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Adverse Reactions
- Regulatory Milestones by Region
- Deals and Partnerships
3. Product Details
4. Zelboraf Sales Assessment
- Historical Sales
- Forecasted Sales
5. Patent Details
6. Global API Manufacturers Assessment
- Active Pharmaceutical Ingredient (API) Manufacturers by Country
- Active Pharmaceutical Ingredient (API) Manufacturers by Region
7. Market Competition
8. Emerging Therapies
8.1 Drug 1: Company 1
- Product Description
- Research and Development
- Product Development Activities
9. SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/research/2xsbqm/zelboraf_drug?w=4
